Name
Workshop Track : The State of Suicide in Indiana Session Name: Why the Indiana Suicide Rate Will Continue to Rise and What We Can Do about It
Date & Time
Thursday, December 10, 2020, 3:00 PM - 3:45 PM
Christopher Drapeau
Description

The suicide rate in Indiana has been higher than the national average since 2000, with the 2017 suicide rate representing the highest observed Indiana suicide rate in at least three decades. Suicides have been increasing across the country along with increasing concerns about the COVID-19 pandemic’s influence on short and long-term mental health and economic stability. Indiana, and the US, have benefited from increased awareness, research, grant funding, and community action related to suicide prevention. Yet the suicide rate across the US states continue to rise. This workshop will directly address these issues and introduce avenues for participants to share how they think Indiana should be approaching the topic of suicide. More specifically, this workshop will: 1) introduce participants to Indiana’s new state suicide prevention director, 2) outline reasons why Indiana will continue to see annual increases in suicide, and 3) will conclude with a call to action. This call to action will outline initial ideas from the state suicide prevention director on how Indiana can slow the increase in suicides, how participants can add their voice to the discussion and/or get more involved in Indiana suicide prevention efforts, and will include an invitation to those already involved in state suicide prevention to think about how to tweak traditional methods and explore novel approaches.hat of the Covid-19 pandemic. At the time of this writing, more than 8 million Americans have tested positive for Covid-19 and over 220,000 people have died of this disease. Individuals struggling with substance use disorder (SUD) or those in recovery may find COVID-19 and the non-medical impacts of COVID-19 more difficult than the general population. There has been an increase in substance use for those with a period of remission and social isolation has led to increases in depression, anxiety, domestic violence, and other mental health disorders. With this “triple threat” of opioids, stimulants, and Covid-19, we need to rethink how we assess, support and deliver treatment to those with SUD.